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ABSTRACT 
 
The anti-inflammatory effect of selagin-7-O-(6″-O-Acetyl-)-β-D-glucoside, isolated from the 
medicinal herb Cancrinia discoidea (Ledeb.) Poljak, was evaluated for its anti-
inflammatory activity in the carrageenin- and serotonin-induced rat paw oedema models of 
acute inflammation and the cotton pellet-induced granuloma rat model of chronic inflamma-
tion. Flavone glycoside at doses of 5, 10, or 20 mg/kg, the clinical anti-inflammatory indo-
methacin at 10 mg/kg, or vehicle were administered orally before injection of the pro-
inflammatory compound. The test compound showed significant anti-inflammatory activity 
against paw edema induced by carrageenin or serotonin, most notably at the highest test dose 
of 20 mg/kg. In the cotton pellet-induced granuloma model, the compound showed dose-
dependent anti-inflammatory activity, with the highest effect at 20 mg/kg. In all three assays, 
the flavone glucoside compound was more active at 20 mg/kg than indomethacin at 
10 mg/kg.  
 
Keywords: Cancrinia discoidea (Ledeb.) Poljak, selagin-7-O-(6″-O-Acetyl-)-β-D-glucoside, 
anti-inflammatory activity  
 
 
INTRODUCTION 
Inflammation is a physiological reaction 
to injury or to infectious, allergic, or chemi-
cal irritation. Inflammatory processes are 
complex biochemical phenomena character-
ized by tissue edema, pain, and leukocyte 
infiltration (Vickerstaff and Bielory, 1990). 
The most common clinical treatments for 
inflammatory diseases are nonsteroidal or 
steroidal anti-inflammatory compounds 
(Rainsford, 2007). The use of steroidal 
drugs as anti-inflammatory agents is now 
controversial, however, due to their multi-
ple side effects (Schäcke et al., 2002). 
Therefore, it is necessary to develop new 
agents with more powerful anti-inflamma-
tory activities but with fewer side effects. 
Indigenous medicinal plants are possible 
sources of novel anti-inflammatory with 
more tolerable side effects. 
The genus Cancrinia, classified in sub-
tribe Matricariinae of the Anthemideae, 
consists of about 30 species of subshrubs 
and herbaceous perennials native to Central 
Asia. Cancrinia discoidea, a perennial herb 
of genus Cancrinia, is mainly distributed in 
the mountains of western China and Central 
Asia (Yu and Li, 1997). This plant has been 
harvested both as an important edible in-
vigorant and medicinal herb to cure several 
ailments such as inflammation, dermal ul-
cer, bleeding, and stomach-ache in tradi-
tional folk medicine. In addition to use in 
traditional medicine, C. discoidea has been 
described as an important invigorant. In a 
previous study, we isolated a number of fla-
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vonoids from C. Discoidea, including a new 
flavone glycoside, selagin-7-O-(6″-O-Ace-
tyl-)-β-D-glucoside, and demonstrated that 
this flavone glycoside exhibited effective 
inhibitory activity against human neutrophil 
O2·- generation (Zhu and Tian, 2010).  
The aim of this study was to investigate 
the anti-inflammatory potential of this new 
flavone glycoside (Figure 1). In the present 
work, the flavone glycoside was evaluated 
for its anti-inflammatory activity in two 
acute and one chronic model of inflamma-
tion in rats, and the anti-inflammatory re-
sponse was compared to the clinical anti-
inflammatory indomethacin.  
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Figure 1: Structure of selagin-7-O-(6″-O-
Acetyl-)-β-D-glucoside 
 
MATERIALS AND METHODS 
Test materials 
The isolation and structure elucidation 
of selagin-7-O-(6″-O-Acetyl-)-β-D-gluco-
side was reported before (Zhu andTian, 
2010). Carrageen, serotonin and indometha-
cin were purchased from Sigma-Aldrich.  
 
Animals  
Male and female Sprague Dawley rats, 
42 to 45 days old, were obtained from the 
Laboratory Animal Center, Sun Yat-sen 
University. The animals were quarantined 
and acclimatized for a week before the 
treatment. Rats of either sex, weighing 180–
210 g, were randomly selected and assigned 
to treatment and control groups using a 
computer randomization process. The ani-
mals were housed in autoclaved polyethyl-
ene cages (4 rats in each group per cage) 
and maintained on a 12:12 h light:dark cy-
cle. The temperature and relative humidity 
of the animal room were maintained at 23 ± 
2 °C and 50-70 %.  
 
Carrageenin-induced paw edema  
Animals of either sex were divided into 
five groups of eight animals each. The first 
group (negative control) received the vehi-
cle only (distilled water). Animals of the 
second, third, and fourth groups were 
treated orally with the flavone glycoside at 
doses of 5, 10, or 20 mg/kg. Group 5 (posi-
tive control) received indomethacin at 
10 mg/kg. Thirty min after drug administra-
tion, edema was induced by the injection of 
0.1 mL 1 % carrageen in normal saline into 
the plantar aponeurosis of the right hind 
paw. Hind paw volume (an index of swell-
ing) was measured using a plethysmograph 
before injection and at 1, 2, 3, 4, and 5 h 
after carrageenin injection (Winter et al., 
1962). The difference between the initial 
and subsequent paw volume reading gave 
the actual oedema volume. The percent in-
hibition of inflammation was calculated us-
ing the formula: 
% inhibition=100(1-Vt/Vc), 
where Vc represents oedema volume in 
control and Vt the oedema volume in the 
group treated with the tested flavone or in-
domethacin.  
 
Serotonin induced paw edema  
Animals of either sex were divided into 
five treatment groups of eight animals each. 
The negative control group received dis-
tilled water vehicle only. Animals of the 
second, third, and fourth groups were 
treated orally with the flavone glycoside at 
5, 10, or 20 mg/kg. The positive control 
group received indomethacin at 10 mg/kg. 
Thirty min after drug administration, edema 
was induced by the injection of 0.05 mL 
serotonin, freshly prepared in normal saline, 
into the plantar aponeurosis of the right 
hind paw. Hind paw volumes were meas-
ured using a plethysmograph before injec-
tion and at 1, 2, 3, 4, and 5 h after serotonin 
injection (Maity et al., 1998). The change in 
paw volume was taken as actual oedema 
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RESULTS AND DISCUSSION volume. The percent inhibition of inflam-
mation was calculated using the formula: Inflammation is a ubiquitous response 
of living tissues to injury. It involves a 
complex cascade of enzyme activation, cy-
tokine release, extravasation of fluid, cell 
migration, tissue breakdown, and repair 
(Vane and Bolting, 1995). Flavonoids are 
important constituents of plants that exhibit 
a variety of beneficial effects on human 
health. The anti-inflammatory properties of 
various flavonoid glycosides have been 
studied in order to establish and character-
ize their potential utility as therapeutic 
agents for the treatment of inflammatory 
diseases (Gil et al., 1994; Rotelli et al., 
2003; Guardia et al., 2001). In the present 
study, three different animal models were 
employed to evaluate of anti-inflammatory 
potential of selagin-7-O-(6″-O-Acetyl-)-β-
D-glucoside. 
% inhibition=100(1-Vt/Vc), 
where Vc represents oedema volume in 
control and Vt the oedema volume in the 
group treated with the tested flavone or in-
domethacin.  
 
Cotton pellet-induced granuloma 
Rats of either sex were divided into five 
groups of eight each. Inflammation was in-
duced by the method of Mosquera et al. 
(2011) with slight modifications. The ani-
mals were anesthetized with ketamine 
(50 mg/kg) (i.m.). The back skin was 
shaved and disinfected with 70 % ethanol 
and an incision made in the lumbar region. 
Subcutaneous tunnels were formed by 
blunted forceps and a sterilized, pre-
weighed cotton pellet (15±1 mg) was 
placed on both sides in the scapular region. 
The animals were treated orally with dis-
tilled water as negative control, indometha-
cin as the positive control drug (10 mg/kg), 
or 5, 10, or 20 mg/kg of flavone glycoside 
daily for 7 days. On day 8, the animals were 
sacrificed and the pellets were dissected 
out. They were dried in an oven at 60 °C 
until the weight stabilized. The net dry 
weights (initial minus final) were deter-
mined. Wet content and dry content were 
determined using the formulae:  
The anti-inflammatory effect of the fla-
vone glycoside in the carrageenin-induced 
rat paw oedema model is shown in Table 1 
and the percent inhibition of inflammation 
is shown in Table 2. In all treated groups, 
subplantar injection of carrageenin (0.1 mL, 
1 % w/v) produced strong oedema in the rat 
paws, reaching a maximum after 3 h and 
generally starting to decrease thereafter. 
Our results revealed that selagin-7-O-(6″-
O-Acetyl-)-β-D-glucoside possessed potent 
anti-inflammatory activity against the acute 
phase of inflammation. The experimental 
group with the highest test dose (20 mg/kg) 
exhibited a significant anti-inflammatory 
effect, starting after 3 h (p < 0.05); the ac-
tivity was higher than observed for the 
standard drug indomethacin (10 mg/kg). 
The experimental groups with lower doses 
exhibited less inflammation than the nega-
tive control but more than the positive con-
trol. Percentage of inflammation and inhibi-
tion at different times for both genders of 
control and treated rats were not signifi-
cantly different. Carrageenin-induced paw 
edema is a prominent experimental model 
for acute inflammation. Development of 
edema induced by carrageenan has been 
described as biphasic (Vinegar et al., 1969). 
Wet content = weight of the cotton pellet 
(wet) - weight of the cotton pellet (dry) 
Dry content = weight of the cotton pellet 
(dry) - weight of the cotton pellet. 
 
Statistical analysis  
Data are presented as means ± standard 
deviation (SD). For statistical analysis, data 
were analyzed by the one-way ANOVA 
followed by a Duncan post-hoc for pair-
wise comparisons between groups. A 
p < 0.05 indicated a significant difference 
between the groups. 
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Table 1: Acute anti-inflammatory activity of the test compound in the carrageenin-induced rat paw  
oedema model 
 
Percentage of inflammation at time (h)  
Initial 1 h 2 h 3 h 4 h 5 h 6 h 
Negative control 8.3±0.4 31.0±4.5 40.2±5.8 49.5±8.1 43.7±7.8 40.5±5.4 25.6±4.8 
5 mg/kg 8.2±0.5 29.2±4.2 36.6±5.6 34.6±6.6 30.2±7.5* 26.3±6.4* 14.2±3.6* 
10 mg/kg 8.3±0.2 28.3±4.6 34.1±5.7 32.9±5.8* 23.6±4.2* 20.6±5.4* 5.4±3.2* 
20 mg/kg 8.4±0.4 28.6±4.8 32.8±5.9 25.5±6.5* 16.3±6.8* 12.8±3.5* 4.0±2.0* 
Indomethacin  
(10 mg/kg) 
8.4±0.4 28.1±2.7 32.4±3.8 32.5±5.2* 26.4±5.9* 17.1±4.5* 4.9±2.5* 
Values are expressed as mean ± SD (n = 8).  
*p<0.05 compared to the negative control 
 
 
Table 2: Acute anti-inflammatory activity against carrageenin-induced rat paw oedema expressed as: 
percent of inhibition of oedema formation at time (h) 
 
Percentage of inhibition at time (h)  
1 h 2 h 3 h 4 h 5 h 6 h 
5 mg/kg 5.8 9.0 30.1 30.9 35.1 44.5 
10 mg/kg 8.7 15.2 33.5 46.0 49.1 78.9 
20 mg/kg 7.7 18.4 48.5 62.7 68.4 84.4 
Indomethacin 
(10 mg/kg) 
9.4 19.4 34.3 39.6 57.8 80.9 
 
 
 
Following carrageenan injection, there 
was a sudden elevation of paw volume 
compared to histamine and serotonin injec-
tion (Lo et al., 1982), after which increased 
vascular permeability was maintained by 
the release of kinins up to 2.30 h. From 
2.30 to 6 h after carrageenan injection, the 
inflammatory mediators appeared to be 
prostaglandins, the release of which is 
closely associated with migration of leuco-
cytes into the inflamed site (Brito and An-
tonio, 1998). It had been demonstrated that 
flavone glycoside is able to inhibit the en-
zymes responsible for prostaglandin syn-
thesis, as well as other mediators of the 
inflammatory process.  
The anti-inflammatory effect of the 
flavone glycoside in the serotonin-induced 
rat paw oedema model is shown in Table 3, 
and the percent inhibition of inflammation 
is shown in Table 4. The experimental 
group receiving the highest test dose 
(20 mg/kg) exhibited a significant anti-
inflammatory effect, starting 3 h after sero-
tonin injection (p < 0.05). Again, the in-
flammatory response was lower than ob-
served for indomethacin at 10 mg/kg, 
while the experimental groups receiving 
lower doses showed less inflammation than 
the negative control but more than the 
positive control. Percentage of inflamma-
tion and inhibition at different times for 
both genders of control and treated rats 
were not significantly different. The fla-
vone glycoside mediates these anti-
inflammatory actions by either inhibiting 
the synthesis, release, or action of inflam-
matory mediators involved in inflamma-
tion.  
 
 
 
 113 
EXCLI Journal 2011;10:110-116 – ISSN 1611-2156 
Received: June 17, 2011, accepted: August 14, 2011, published: August 16, 2011 
 
Table 3: Acute anti-inflammatory activity of the test compound in the serotonin-induced rat paw  
oedema model 
Percentage of inflammation at time (h)  
Initial 1 h 2 h 3 h 4 h 5 h 6 h 
Negative control 12.4±0.6 28.5±5.6 51.3±6.8 63.4±6.9 42.2±7.6 24.8±6.8 12.6±5.2 
5 mg/kg 12.5±0.5 28.2±5.3 48.2±6.7 53.3±5.8 29.4±6.2* 16.1±6.3* 7.1±3.5* 
10mg/kg 12.3±0.6 27.8±6.1 45.2±5.9 45.7±5.9 24.5±5.6* 13.4±5.4* 5.4±2.7* 
20 mg/kg 12.4±0.6 26.7±5.9 43.2±5.6 37.5±6.2* 18.3±7.2* 10.7±4.6* 2.6±1.5* 
Indomethacin  
(10 mg/kg) 
12.3±0.5 26.5±5.6 43.2±5.4 38.4±7.1* 25.8±7.6* 12.4±5.4* 4.8±3.5* 
Values are expressed as mean ± SD (n = 8); * p<0.05 compared to the negative control 
 
Table 4: Acute anti-inflammatory activity against serotonin-induced rat paw oedema expressed as the 
percent of inhibition of oedema formation at time (h) 
Percentage of inhibition at time (h)  
1 h 2 h 3 h 4 h 5 h 6 h 
5 mg/kg 1.1 6.0 15.9 30.3 35.1 43.7 
10 mg/kg 2.5 11.9 27.9 41.9 46.0 57.14 
20 mg/kg 6.3 15.8 40.9 56.6 56.9 79.4 
Indomethacin 
(10 mg/kg) 
7.0 15.8 39.4 38.9 50 61.9 
 
In order to assess the test compound’s 
efficacy against the later proliferative phase 
of inflammation caused by tissue degenera-
tion and fibrosis, we used the cotton pellet 
granuloma test. Table 5 shows the effect of 
the flavone glycoside on cotton pellet-
induced granuloma formation in rats. 
Maximal inhibition (45.1 %) of granuloma 
formation was observed at a dose of 
20 mg/kg (p < 0.05), and this effect was 
greater than that of indomethacin at 
10 mg/kg (41.7 % inhibition). Treatment 
groups with lower doses of the flavone gly-
coside showed a smaller anti-inflammatory 
effect than the positive control. Percentage 
of inhibition for both genders of control and 
treated rats were not significantly different. 
In the cotton pellet granuloma model, in-
flammation and granuloma develop over a 
period of several days. This model tests bio-
activity against the proliferative phase of 
inflammation. This later phase of inflamma-
tion involves the proliferation of macro-
phages, neutrophils, and fibroblast, and 
multiplication of small blood vessels, which 
are the basic sources of the highly vascular-
ized reddish mass termed granulation tissue 
(Bhattacharya and Nag Chaudhuri, 1992). 
Hence, a decrease in the granuloma weight 
indicates a suppression of the proliferative 
phase mediated by the flavone glycoside. 
 
 
 
Table 5: Chronic anti-inflammatory activity of the test compound on cotton pellet induced granuloma 
model in rats 
Group Wet content of 
granuloma (mg) 
Inhibition (%) Dry content of 
granuloma (mg) 
Inhibition 
(%) 
Negative control 48.6±10.2 – 324.6±46.2 – 
5 mg/kg 43.2±10.5 11.1 243.5±30.6 25.0 
10 mg/kg 38.1±13.9 21.6 206.8±25.7* 36.3 
20 mg/kg 35.4±11.7 27.2 178.3±35.4* 45.1 
Indomethacin (10 mg/kg) 36.4±12.6 25.1 189.2±30.7* 41.7 
Values are expressed as mean ± SD (n = 8); * p<0.05 compared to control 
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CONCLUSION 
Taken together, the results strongly 
suggest that selagin-7-O-(6″-O-Acetyl-)-β-
D-glucoside isolated from C. discoidea 
possesses anti-inflammatory effects, sup-
porting the use of C. discoidea in tradi-
tional medicine.  
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